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Abstract
Background: Macrophages and adipocytes contribute to
release of cytokines resulting in the chronic inflammatory
profile of the metabolic syndrome. The local increase of
proinflammatory cytokines impairs adipogenesis, resulting in
formation of dysfunctional adipocytes that are unable to store
and handle lipids. The altered lipid fluxes in/from adipocytes
affect whole-body metabolism. We investigated the role of
androgens on adipocyte-derived proinflammatory and anti-
inflammatory cytokines during preadipocyte differentiation.
Materials and methods: Various differentiation methods
were used to obtain full conversion of 3T3-L1 into mature
adipocytes. The degree of adipocyte conversion in the pres-
ence/absence of dihydrotestosterone (DHT) was analyzed by
measuring intracellular triglycerides (Oil Red O staining).
The effects of DHT administration on interleukin 1b (IL-
1b), IL-2, IL-6, IL-10, IL-12, interferon g (IFNg) and tumor
necrosis factor a (TNFa) secretion was measured at days 0,
4, 6 and 8 of differentiation using the SearchLight multiplex
protein array.
Results: DHT regulates a number of cytokines in committed
and mature 3T3-L1 adipocytes. IL-1b and TNFa were read-
ily suppressed at the very early stages of differentiation.
IFNg release was inhibited at day 4, but the effect was no
longer detectable on day 8. IL-6 and IL-12 were significantly
reduced at day 8 of differentiation. Conversely, the differ-
entiation-dependent increase of IL-2 and IL-10 was further
stimulated by DHT since day 0.
Conclusions: We provide evidence that androgens promote
an anti-inflammatory profile that parallels the acquisition of
a functional adipocyte phenotype. The crosstalk between
androgens, adipocyte-derived mediators of inflammation and
intracellular lipid fluxes could have profound implications
on metabolism of men with obesity and metabolic syndrome.
Keywords: adipogenesis; adipokines; metabolic syndrome;
obesity; testosterone.
*Corresponding author: Andrea M. Isidori, MD, PhD, Department
of Experimental Medicine, Sapienza University of Rome, Viale
del Policlinico 155, 00161 Rome, Italy
Phone: q39-0649970540, Fax: q39-064455345,
E-mail: andrea.isidori@uniroma1.it
Received October 14, 2010; accepted October 15, 2010;
previously published online January 21, 2011
Introduction
The chronic, low-grade, inflammatory state characterizing
metabolic diseases, such as obesity and endothelial dysfunc-
tion, is sustained by adipokines and by proinflammatory
mediators released, locally, by white adipose tissue. The dif-
ferential contribution of committed preadipocytes and mature
adipocytes to the pool of secreted adipokines has recently
been investigated (1). In normal conditions, immature pre-
adipocytes contributes more, than mature adipocytes, to the
proinflammatory state, because these cells exhibit a higher
expression of plasminogen activator inhibitor-1 (PAI-1),
interleukin 6 (IL-6), vascular endothelial growth factor, mono-
cyte chemoattractant protein-1 (MCP-1), IL-4 and IL-8. Con-
versely, adiponectin, a marker of adipocytes, is found at
higher levels in adipocytes and absent in preadipocytes. If
exposed to tumor necrosis factor a (TNFa), both preadipo-
cytes and adipocytes show an increase of TNFa mRNA
expression, leading to an augmented ability to activate endo-
thelial cells and recruit monocytes. The same autocrine reg-
ulation was demonstrated in humans (2).
In metabolic syndrome, monocytes/macrophages accu-
mulate lipids and infiltrate adipose tissue; in turn, adipocytes
become fatter, larger and express novel molecules acquiring
a ‘macrophage-related gene profile’ (3, 4). In such a vicious
cycle, the distinction between adipocytes and macrophages
becomes subtle. Indeed, there is a close relationship between
immune and adipose cells, as reported in a study using a
transcriptome profiling approach aimed at comparing mac-
rophages and adipocytes (5). Macrophages and adipocytes
both develop from mesoderm, but separate relatively early
in embryogenesis, along with hematopoietic and mesenchy-
mal lineages. Nevertheless, adipocyte and monocyte/macro-
phages are known to share many functional and antigenic
features. In particular, if exposed to mediators of inflam-
mation, the ability of adipocytes to secrete inflammatory
cytokines, such as TNFa and IL-6, is enhanced (6, 7). Using
profiling analysis, it was unequivocally demonstrated that
adipose precursors can transdifferentiate into macrophages,
in agreement with numerous studies on cellular plasticity in
which the direct contact with differentiated cells induces the
precursors to achieve the same specialized phenotype. There-
fore, in fat tissue from obese patients, a fraction of infiltrated
macrophages develops from transdifferentiation of stromal
preadipocytes. High levels of proinflammatory cytokines in
adipose tissue are positively related to insulin resistance,
development of type 2 diabetes and obesity (8–11). Overall,
the activation of adipose cells by the macrophage-derived
mediators and the potent contribution of the other stromo-
vascular fraction create a regulatory loop that strengthens the
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concept of a proinflammatory environment underlying met-
abolic disorders.
Pleiotropic effects of proinflammatory cytokines on adi-
pose cells concern each stage of cell maturation. The impair-
ment of the differentiation of the precursors and the
inhibition of lipogenesis of new formed fat cells eventually
leads to the formation of dysfunctional fat cells and to the
worsening of the metabolic status (12).
The concept that sex steroids can modulate the immune
system is in agreement with a higher incidence of autoim-
mune disorders in women compared to men (13, 14). Sex
hormones have effects on cells of both the innate and adap-
tive response. An estrogen hormonal environment stimulates
Th lymphocytes to secrete type 2 cytokines (IL-4, IL-5, IL-6,
IL-10 and IL-13) that promote the synthesis of antibodies
(15, 16). By contrast, androgens stimulate Th cells to pro-
duce type 1 cytokines (IFNg, IL-2, TNFa) which reduce Th2
activity and stimulate cell-mediated immunity (17).
In macrophages, a differentiated effect of sex hormones
can be observed. Estrogens stimulate the production of IL-
1, IL-4, IL-6 and IL-10. By contrast, testosterone selectively
increases the production of IL-1b and of IL-12 in monocytes
(18). Moreover, testosterone does not show any effect on the
production of TNFa (18), whereas with regard to estrogens,
there are contradictory results concerning their action on the
production of this cytokine by monocytes (19, 20).
With the present study, we sought to investigate the effect
of androgens on the ability of adipocytes to secrete proin-
flammatory and anti-inflammatory cytokines. Using a well-
established cellular model (3T3-L1), we studied the trend of
IL-1b, IL-2, IL-6, IL-10, IL-12, IFNg and TNFa production
during preadipocyte-to-adipocyte conversion obtained with
different differentiation methods (21); we then investigated
how dihydrotestosterone (DHT) can affect such a differen-
tiation-dependent pattern of cytokine release from the non-
immune component of the adipose tissue.
Materials and methods
Cell culture conditions and treatment
Mouse 3T3-L1 fibroblasts were purchased from American Type
Culture Collection (ATCC, Manassas, VA, USA) and were grown
in 10% CO2 in air at 378C to confluence in Dulbecco’s modified
Eagle’s medium (DMEM, Sigma-Aldrich, St. Louis, MO, USA)
containing 10% newborn calf serum (NCS, Sigma-Aldrich),
100 units/mL penicillin and 100 mg/mL streptomycin (P/S, Sigma-
Aldrich). Two days after confluence, the conversion of fibroblasts
into mature adipocytes was induced by adding cells with DMEM
containing 10% NCS, P/S and a differentiation cocktail (Cocktail
1: 1 mM dexamethasone, 0.5 mM IBMX and 10 mg/mL insulin;
Cocktail 2: 125 mM indomethacin, 5 mg/mL insulin) (day 0). Dif-
ferentiation medium was removed after 48 h and replaced by
DMEM containing 10% NCS, P/S and 5 mg/mL insulin. Since day
0 and each 2 days, culture medium was changed and DHT supple-
mentation was renewed in treated samples. Cell supernatants for
cytokine assays were collected before the administration of the
cocktail (day 0), at day 4, day 6 or at complete differentiation (day
8), after 60 h of serum starvation (medium supplemented with BSA
2% and insulin "DHT). Cell supernatants were withdrawn, centri-
fuged to eliminate debris and frozen at –808C for further analyses.
Quantification of lipid accumulation
Oil Red O staining followed by spectrophotometric analysis was
performed to measure lipid accumulation as previously described
(22). Cells from three different wells were washed with phosphate
buffered saline (Sigma-Aldrich) and fixed with 3.7% (v/v) formal-
dehyde (Sigma-Aldrich) for 1 h. A filtered 0.6% (w/v) Oil Red O
dye (Sigma-Aldrich) in 60% (v/v) isopropanol was used. Wells were
washed three times with distilled water and excess water was evap-
orated at 608C for 1 h. Oil Red O dye retained by lipid droplets
was extracted by adding 100% isopropanol. The optical density of
this solution was measured at a wavelength of 490 nm and results
were expressed as percentage of Oil Red O absorbance of untreated
cells control at the selected day "SD.
SearchLight multiplex ELISA
The measurement of proteins in cell supernatants (IL-1b, IL-2, IL-
6, IL-10, IL-12, IFNg and TNFa) was performed using the
SearchLight Protein Array Technology (Pierce Biotechnology,
Rockford, IL, USA). This method consists of a multiplexed sand-
wich ELISA system and is used for the simultaneous quantitative
measurement of analytes for which respective capture-antibodies are
spotted in arrays within each well of a 96-well microplate. The
multiplex ELISA assay was performed according to the manufac-
turer’s instructions; 50 mL of calibration standards or samples were
analyzed twice and the mean value of measurements was used. The
final chemiluminescent signal was detected with a cooled CCD
camera (Aushon BioSystems, Billerica, MA, USA). The concentra-
tion of each analyte in the array was quantified by comparing the
spot intensities for each unknown sample to the corresponding stan-
dard curves calculated from the standard sample results by the
SearchLight Array Analyst Software. Integrated density values were
proportional to the concentrations of bound proteins. Individual ana-
lytes were identified by the position of each specific capture anti-
body within the well. Standard curves, raw data and final pg/mL
concentrations for each analyte and each sample were reviewed in
the array software and exported to Microsoft Excel Software
(Microsoft Corp., USA). Results are expressed as means of three
replicates of three independent experiments. Replicates were ana-
lyzed in duplicate on the 96-well microplate. Statistical comparisons
between two groups were analyzed by Student’s t-test and between
several groups by one-way analysis of variance followed by Stu-
dent’s t-test. Probability values of p-0.05 were considered statis-
tically significant.
Results
Effects of sex steroids on morphology and
triglyceride accumulation during preadipocyte-
to-adipocyte conversion
Preadipocytes showed a fibroblast-like appearance and con-
tained no lipid droplets. After induction of differentiation,
they started to lose the elongated morphology, became spher-
ical and gradually accumulated small lipid droplets. Within
20 days adipocytes appear filled with large lipid vesicles.
The addition to the differentiation cocktail of DHT 10 nM
or 1 mM since day 0, in the presence of insulin and high-
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glucose maintained throughout adipocyte maturation, did not
change the kinetic of differentiation, with the cells becoming
round-shaped and accumulating lipid droplets in a similar
extent to controls. If differentiation was induced by adding
Cocktail 2, we observed a slower acquisition of the differ-
entiated phenotype in both control and hormone-treated cells.
Nevertheless, no difference could be observed in lipid stain-
ing or cell morphology after day 10 of differentiation.
As expected, control and treated adipocytes cultures show-
ed a similar Oil Red O signal, measured at days 6, 10 and
14, reflecting the observed trend of lipid accumulation. This
was verified using both differentiation cocktails (Figure 1).
Effect of androgens on cytokine production during
adipogenesis
IL-1b, IL-2, IL-6, IL-10, IL-12 levels gradually increased
during the conversion of preadipocytes into mature adipo-
cytes (Figure 2). Basal levels of such cytokines at any stage
of the differentiation process are below 15 pg/mL, except for
IL-6 for which levels ranged between 100 and 2000 pg/mL.
By contrast, IFNg and TNFa secretion decreases with the
acquisition of the differentiated phenotype (Figure 2).
IL-2 and IL-10 (Figure 2A) Cells exposed to DHT (10 nM)
show a marked increase of IL-2 levels at later stages of dif-
ferentiation (day 8: 10.7"0.5 pg/mL vs. 3.9"0.6 pg/mL of
control, p-0.001), whereas at the higher dose (1 mM DHT)
they show a sharper increase at earlier stages (day 4: 13.2"
0.8 pg/mL vs. 3.2"1 pg/mL of control, p-0.001), without
further increase.
IL-10 concentration in control cells rapidly reaches a pla-
teau since day 4 of differentiation. Exposure to 10 nM DHT
induces an exponential increase of IL-10 production (day 8:
10.8"1.9 pg/mL vs. 4.1"1.3 pg/mL of control, p-0.001).
IL-1b and TNFa (Figure 2B) Treatment with androgens
blocks the positive trend of IL-1b production. Indeed, expo-
sure to 10 nM DHT induces a rapid plateau of cytokine pro-
duction up to day 8. If exposed to 1 mM DHT, cells do not
show any differentiation-dependent increase of IL-1b. Levels
of the cytokine remain constant since day 4 (p-0.05) and
are 3-fold lower than in control cells at day 8 of differenti-
ation (4.1"1.5 pg/mL vs. 11.9"0.6 pg/mL of control,
p-0.01).
TNFa production shows a decreasing trend during differ-
entiation. Cells treated with both 10 nM and 1 mM DHT
produce less TNFa than control counterparts since day 4 of
differentiation (10 nM and 1 mM DHT, p-0.01). Moreover,
with 1 mM DHT, TNFa levels do not reach those of controls
after the full maturation (day 8: 8.7"1.3 pg/mL vs. 16.4"
1.3 pg/mL of control, p-0.01).
IFNg, IL-6 and IL-12 (Figure 2B) IFNg production is sig-
nificantly decreased in the presence of 1 mM DHT at earlier
stages of differentiation (day 4, p-0.05), reaching levels
similar to control samples at day 8 of differentiation
(788.9"123 pg/mL vs. 734.9"76.3 pg/mL of control, not
significant).
The differentiation-dependent increase of IL-6 is reduced
after exposure to androgens. Indeed, at day 8 IL-6 levels are
lowered by ;1.8-fold with 1 mM DHT (1067.8"357
pg/mL vs. 1891.1"341.4 pg/mL of control, p-0.001).
IL-12 concentration in DHT-treated cells rapidly reaches
a plateau at day 4 of differentiation (p-0.05), as opposite
to the exponential increase of cytokine levels in control cells.
Conclusions
Our study gained new insights into the role of androgens
during adipogenesis. Here, we describe for the first time how
differentiating preadipocytes respond to androgen supple-
mentation in terms of cytokine production. In adipose tissue,
both immune and adipose cells contribute to the cytokine
microenvironment. In the onset of insulin resistance, mac-
rophages and adipocytes influence the biological functions
of each other through the paracrine action of secreted medi-
ators. Macrophage-derived cytokines can affect the matura-
tion of the adipocyte precursor and impair the acquisition of
a specialized phenotype (23). The incomplete differentiation
of preadipocytes leads to the formation of smaller cells with
an altered lipid metabolism that are less responsive to insulin
signaling and produce more proinflammatory cytokines such
as TNFa (24). Therefore, the impairment of differentiation
can be seen as both a cause and a consequence of an altered
cytokine profile within the adipose tissue, leading to the ini-
tiation of a chronic inflammation status that sustain obesity
and diabetes.
In the present study, we demonstrate that androgens have
significant effects on the pool of cytokines secreted by newly
formed adipocytes. Indeed, the administration of DHT to dif-
ferentiating 3T3-L1 preadipocytes significantly decreases the
release of proinflammatory cytokines (IL-1b, IL-6, TNFa,
IFNg and IL-12), whereas anti-inflammatory cytokines (IL-
2 and IL-10) are increased during the adipogenic process.
IL-2, a cytokine critical for T cell growth and develop-
ment, has been shown to induce adiponectin secretion in
human adipocytes, an adipokine with insulin-sensitizing and
anti-inflammatory properties (25). IL-10 is a strong anti-
inflammatory cytokine that is able to inhibit TNFa, IL-1b
and IFNg secretion from macrophages (26) and do not affect
adipocyte formation or adiponectin secretion (23). Here, we
demonstrate that, if preadipocytes are differentiated in the
presence of DHT, the differentiation-dependent increase of
IL-2 and IL-10 release is further stimulated.
By contrast, DHT is able to completely revert the trend of
release of IL-1b and TNFa. Indeed, in both cases with 1 mM
DHT, the production of such cytokines is effectively sup-
pressed since the very early stages of differentiation. A less
marked effect is observed for IFNg, for which levels are
significantly lowered at day 4 only with the higher DHT
concentration, but eventually equal those of control cells at
the end of the adipogenic conversion (day 8). The same trend
is observed on TNFa if cells are administered with 10 nM
DHT. IL-6 and IL-12 release is significantly reduced only
with 1 mM DHT at day 8 of differentiation.
AUTHOR’S COPY | AUTORENEXEMPLAR 
AUTHOR’S COPY | AUTORENEXEMPLAR 
486 Pierotti et al.: Androgens on inflammatory adipokines
Article in press - uncorrected proof
Figure 1 Quantification of adipocyte development by measuring lipid accumulation (Oil Red O staining) at days 6, 10 and 14 of differ-
entiation after treatment with dihydrotestosterone.
Oil Red O staining of intracellular triglycerides was performed at days 6, 10 and 14 of differentiation. (Upper panel) Representative culture
dishes at days 0, 2, 6, 10 and 14 of differentiation with either Cocktail 1 or Cocktail 2. (A) Cells differentiated with Cocktail 1:
dexamethasoneqIBMXqinsulin. (B) Cells differentiated with Cocktail 2: indomethacinqinsulin (see Methods). White bars represent
untreated cells, gray bars represent cells receiving 10 nM DHT and black bars represent cells receiving 1 mM DHT since day 0 of
differentiation. Results are means"SD (ns3). Difference compared to untreated cultures is not significant (p)0.05) at any DHT dose at
any time (ns).
It has been demonstrated that IL-1b, IFNg and TNFa
inhibit the differentiation of adipose precursors, promote the
maintenance of a fibroblast-like phenotype, support a prolif-
erative state with conserved Wnt signaling and induce the
secretion of inflammatory markers such as IL-6, MCP-1 and
PAI-1 (23). Moreover, TNFa is able to induce a dediffer-
entiation of mature adipocytes and inhibits the expression of
several genes of normal metabolism and insulin sensitivity
such as glycerol-3-phosphate dehydrogenase, lipoprotein lip-
ase, acetyl-CoA carboxylase, fatty acid synthase (27), IRS1
and GLUT4 (28). IL-6 shows a similar, although less potent,
anti-adipogenic effect. Consistently with their antidifferentia-
tive effect, exposure of subcutaneous human preadipocytes
to IL-1b, IFNg and TNFa completely blocked adiponectin
secretion (23). TNFa stimulation is also able to induce a
sharp increase of IL-12 in 3T3-L1, suggesting that IL-12 is
strongly related to the inflammatory status (29).
The finding that androgens can act as a prodifferentiative
force arises from the dual effect of DHT observed in devel-
oping adipocytes. On one hand, androgen added to the dif-
ferentiation medium causes a fast drop of proinflammatory
antidifferentiative cytokines (TNFa, IL-1b and IFNg), and
on the other hand, this occurs without changes in the rate
and magnitude of lipid accumulation. The androgen-induced
reduction of TNFa, IL-1b and IFNg from the microenviron-
ment that is nourishing the differentiating cell has positive
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Figure 2 Differentiation-dependent secretion of cytokines after treatment with DHT. Levels of each cytokine were measured by the
SearchLight multiplex ELISA at days 0, 4, 6 and 8 of differentiation and results are expressed in pg/mL. White squares are the untreated
cells, gray squares are cells receiving 10 nM DHT and black squares are cells receiving 1 mM DHT since day 0 of differentiation. (A)
Anti-inflammatory cytokine secretion. (B) Proinflammatory cytokine secretion. Three independent experiments were performed. *p-0.05,
**p-0.01, ***p-0.001 indicate significant difference compared to the untreated culture at the corresponding day of differentiation.
repercussions on insulin-sensitivity, glucose internalization
and the acquisition of a mature phenotype. Confirmation of
the beneficial effects is strengthened by the decrease of IL-
6 and IL-12, and the increase of IL-2 and IL-10 observed at
the final stage of adipogenesis. Moreover, we found that in
the presence of prodifferentiative conditioning, DHT does
not alter the rate of lipid accumulation, as measured by Oil
Red O triglyceride staining. Overall, exposure to androgens
during the activation and the progress of the adipogenic con-
version induces a dissociation of fat accumulation and cyto-
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kine secretion that contributes to the successful maturation
into adipose cells with a better metabolic profile.
In conclusion, we have provided evidence that androgens
have significant effects on the ability of differentiating pre-
adipocytes to release proinflammatory (IL-1b, TNFa, IFNg,
IL-6 and IL-12) and anti-inflammatory cytokines (IL-2 and
IL-10). Androgens are shown to promote the formation of
an anti-inflammatory milieu that favors adipose cell matur-
ation, independently of intracellular fat accumulation. The
crosstalk between androgens and immunomodulatory medi-
ators might play a role in ameliorating the chronic inflam-
matory status and, in turn, the adipose cell dysfunction that
are common features of the metabolic syndrome.
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